Medical News

RSS

Positive results from azide drug-loaded Emulsiphan preclinical toxicity study

Cornerstone Pharmaceuticals, Inc., a leader in cancer metabolism-based therapeutics, today announced encouraging results of a preclinical toxicity study of azide drug-loaded Emulsiphan nano emulsions conducted with the National Cancer Institute (NCI) under a Collaboration Agreement. Emulsiphan is Cornerstone's proprietary nanoparticle drug delivery system.

14 Mar 2011

Canon Digital Radiography Systems installed across multiple hospitals in Mexico

Broadening the Company's international reach, Canon U.S.A., Inc., a leader in digital imaging, today announced the installation of 178 digital radiography systems integrated with Canon brand CXDI-50G and CXDI-55G Digital Radiography Systems in various hospitals throughout Mexico through its local distributors, including Casa Plarre S.A. de C.V., helping to reaffirm Canon's commitment to provide quality medical equipment to help facilitate better patient care.

14 Mar 2011

Biodel selects BIOD-105, BIOD-107 recombinant human insulin formulations for clinical testing, development

Biodel Inc. announced today that it has selected two new formulations of recombinant human insulin for clinical testing and is accelerating clinical development plans of these mealtime insulin drug candidates. The new formulations, BIOD-105 and BIOD-107, are designed to result in more rapid insulin action compared to currently marketed meal time insulin analogs while maintaining an injection site tolerability profile comparable to currently marketed insulins.

14 Mar 2011

KAI initiates enrollment in KAI-4169 Phase 2 study for secondary hyperparathyroidism

KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease (ESRD).

14 Mar 2011

LA Times: Q & A with Surgeon General Regina Benjamin

U.S. Surgeon General Dr. Regina M. Benjamin wants to make America healthier, one community at a time.

14 Mar 2011

MEDecision, Health Language enter strategic partnership

MEDecision, Inc., a leading provider of collaborative health management solutions, and Health Language, Inc. (HLI), a global leader in medical terminology management, today announced that the companies have entered into a strategic partnership that will enable MEDecision to help its healthcare payer and provider customers transition to, comply with and capitalize on the industry's forthcoming ICD-10 requirements.

14 Mar 2011

EASL schedules press conference and news briefings during International Liver Congress 2011

The EASL International Liver Congress is an opportunity for over 6,000 clinicians and scientists from around the world to hear the latest research, perspectives and treatments for liver diseases from principal experts in the field. It features a high-calibre and multi-disciplinary scientific programme covering groundbreaking information and in-depth examination of the most essential topics.

14 Mar 2011

State roundup: Medicaid cuts cause unusual bedfellows

Representatives from Arizona hospitals, nursing homes and health plans are set to meet with Gov. Jan Brewer today. They hope to win her support for a plan to impose a tax on their institutions and avoid deep cuts to Arizona's Medicaid program. The plan reportedly includes a cap on funding for childless adults, a group now covered under the Arizona Health Care Cost Containment System that could lose coverage Oct. 1. (Reinhart, 3/11).

14 Mar 2011

Shamir fourth quarter revenues increase 5.4% to $39.1 million

Shamir Optical Industry Ltd., a leading provider of innovative products and technology to the ophthalmic lens market, today announced unaudited financial results for the fourth quarter and year ended December 31, 2010.

14 Mar 2011

Fysicon to customize Merge solutions for BeNeLux market

Merge Healthcare Incorporated, a global corporation dedicated to health IT interoperability solutions, today announced the expansion of its existing software relationship with Fysicon, the dominant Dutch distributor of medical imaging solutions for radiology and cardiology. Fysicon will customize Merge solutions to improve its specific portfolio of image management products for the BeNeLux market

14 Mar 2011

Researchers discover new gene for Sensenbrenner syndrome

Dutch researchers of the Radboud University Medical Center in Nijmegen found a new gene for Sensenbrenner syndrome (Journal of Medical Genetics, 2011 Mar 4). The mutation adds support to the hypothesis that defects in ciliar transport are the cause of the disease. Project leader Dr. Heleen H. Arts is supported by a Kolff Junior Postdoc Grant of the Dutch Kidney Foundation.

14 Mar 2011

WaferGen Biosystems 2010 revenue exceeds guidance

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today reported financial results for the three months and year ended December 31, 2010.

14 Mar 2011

Transcept initiates enrollment in TO-2061 Phase 2 study for treatment resistant obsessive compulsive disorder

Transcept Pharmaceuticals, Inc. today announced the first patient has been enrolled in a Phase 2 clinical study to evaluate TO-2061 as an adjunctive treatment for obsessive compulsive disorder (OCD) in patients who have responded inadequately to currently approved treatments. OCD affects 1 to 2 percent of the United States adult population and can significantly impair the lives of patients and their families.

14 Mar 2011

European Patent Office grants ProtAffin key patent for CellJammer discovery technology

ProtAffin AG, a biotechnology company developing novel biopharmaceuticals for respiratory disease, inflammation and oncology, today announced that it has been granted a key patent by the European Patent Office protecting its CellJammer® discovery technology, which enables the development of a new class of biopharmaceuticals.

14 Mar 2011

Omthera commences dosing in pivotal Epanova Phase III EVOLVE trial in patients with very high triglycerides

Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that the first patient has been dosed in its pivotal Phase III EVOLVE (EpanoVa fOr Lowering Very high triglyceridEs) trial for Epanova™, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega-3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

14 Mar 2011

First Edition: March 14, 2011

In today's headlines, news about the major issues that continue to rise to the surface in the health overhaul debate.

14 Mar 2011

Anacor completes enrollment in AN2728 Phase 2b trial in psoriasis

Anacor Pharmaceuticals announced today that it has completed enrollment in its Phase 2b trial of AN2728, a topical anti-inflammatory product candidate for the treatment of psoriasis. Psoriasis is a chronic inflammatory skin disease that affects approximately 7.5 million people in the United States and over 100 million people worldwide.

14 Mar 2011

Surgeons deliver virtual temporal bone dissection course for otolaryngology residents, physicians

Two surgeons from Central Ohio recently traveled to Nicaragua on a humanitarian mission to treat children with serious ear, nose and throat conditions. However, this year they brought along some help in the form of high-tech equipment designed to appeal to a generation that grew up playing video games - not to entertain the children, but to train the local doctors and medical students.

14 Mar 2011

New research: Rhodopsin pigment in Drosophila may detect temperature

New research from Mount Sinai School of Medicine has discovered that rhodopsin, a pigment of the retina that is responsible for the first events in the perception of light, may also be involved in temperature sensation. This detection had not been revealed in previous studies.

14 Mar 2011

EvaluatePharma data shows poor R&D productivity measures both in quality, quantity

Pharmaceutical R&D productivity is consistently undercounted. Most reports fail to fully count the number of new drugs that reach the market, missing out on billions of dollars of sales generated by R&D investment, an analysis of EvaluatePharma data shows.

14 Mar 2011

Medical News

Positive results from azide drug-loaded Emulsiphan preclinical toxicity study

Canon Digital Radiography Systems installed across multiple hospitals in Mexico

Biodel selects BIOD-105, BIOD-107 recombinant human insulin formulations for clinical testing, development

KAI initiates enrollment in KAI-4169 Phase 2 study for secondary hyperparathyroidism

LA Times: Q & A with Surgeon General Regina Benjamin

MEDecision, Health Language enter strategic partnership

EASL schedules press conference and news briefings during International Liver Congress 2011

State roundup: Medicaid cuts cause unusual bedfellows

Shamir fourth quarter revenues increase 5.4% to $39.1 million

Fysicon to customize Merge solutions for BeNeLux market

Researchers discover new gene for Sensenbrenner syndrome

WaferGen Biosystems 2010 revenue exceeds guidance

Transcept initiates enrollment in TO-2061 Phase 2 study for treatment resistant obsessive compulsive disorder

European Patent Office grants ProtAffin key patent for CellJammer discovery technology

Omthera commences dosing in pivotal Epanova Phase III EVOLVE trial in patients with very high triglycerides

First Edition: March 14, 2011

Anacor completes enrollment in AN2728 Phase 2b trial in psoriasis

Surgeons deliver virtual temporal bone dissection course for otolaryngology residents, physicians

New research: Rhodopsin pigment in Drosophila may detect temperature

EvaluatePharma data shows poor R&D productivity measures both in quality, quantity

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Data management challenges in scientific research

Latest News